Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
399600
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status report for stock acquisition rights with an exercise price adjustment clause
発行・処分する株式数
Shares delivered during the month: 399,600 shares (new shares: 399,600; treasury shares transferred: 0)
発行済株式総数
Exercise ratio subject to exercise restrictions: 1.15% (399,600 shares delivered across all series / 34,666,419 listed shares as of the time of payment for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise price during the month: ¥286.15–¥358.90. Details of the adjustment clause and adjustment floor: not disclosed
Number of Stock Acquisition Rights
Total issued: 86,000; exercised during the month: 3,996; unexercised as of the end of the previous month: 47,921; unexercised as of month-end: 43,925
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
Issued on 8 December 2025: 25th Series Stock Acquisition Rights (with Exercise Price Adjustment Clause). Amount: not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status report for stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | Shares delivered during the month: 399,600 shares (new shares: 399,600; treasury shares transferred: 0) |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 1.15% (399,600 shares delivered across all series / 34,666,419 listed shares as of the time of payment for the issuance) |
| Exercise price | Exercise price during the month: ¥286.15–¥358.90. Details of the adjustment clause and adjustment floor: not disclosed |
| Number of Stock Acquisition Rights | Total issued: 86,000; exercised during the month: 3,996; unexercised as of the end of the previous month: 47,921; unexercised as of month-end: 43,925 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Issued on 8 December 2025: 25th Series Stock Acquisition Rights (with Exercise Price Adjustment Clause). Amount: not disclosed |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the 25th Series Stock Acquisition Rights in March 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.